Furthermore, FHR1 and FHR5 enhance complement activation on ECM proteins indicating that FHRs may contribute to pathological and inflammatory conditions in kidney, eye and joint diseases by modulating the regulatory activity of FH and directly complement activation on ECM. Here, CFHR5 is linked to arthropathy.